rs1150757

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001365276.2(TNXB):​c.7461C>T​(p.Arg2487Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0973 in 1,612,690 control chromosomes in the GnomAD database, including 9,964 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.062 ( 479 hom., cov: 32)
Exomes 𝑓: 0.10 ( 9485 hom. )

Consequence

TNXB
NM_001365276.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.89

Publications

37 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 6-32061428-G-A is Benign according to our data. Variant chr6-32061428-G-A is described in ClinVar as [Benign]. Clinvar id is 261160.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.89 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.7461C>T p.Arg2487Arg synonymous_variant Exon 21 of 44 ENST00000644971.2 NP_001352205.1
TNXBNM_001428335.1 linkc.8202C>T p.Arg2734Arg synonymous_variant Exon 22 of 45 NP_001415264.1
TNXBNM_019105.8 linkc.7461C>T p.Arg2487Arg synonymous_variant Exon 21 of 44 NP_061978.6 P22105-1O95680Q9Y464O95681

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.7461C>T p.Arg2487Arg synonymous_variant Exon 21 of 44 NM_001365276.2 ENSP00000496448.1 P22105-3
TNXBENST00000647633.1 linkc.8202C>T p.Arg2734Arg synonymous_variant Exon 22 of 45 ENSP00000497649.1 A0A3B3ISX9
TNXBENST00000375244.7 linkc.7461C>T p.Arg2487Arg synonymous_variant Exon 21 of 44 5 ENSP00000364393.3 P22105-3

Frequencies

GnomAD3 genomes
AF:
0.0624
AC:
9464
AN:
151754
Hom.:
479
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0155
Gnomad AMI
AF:
0.0703
Gnomad AMR
AF:
0.0297
Gnomad ASJ
AF:
0.0386
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0799
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.106
Gnomad OTH
AF:
0.0468
GnomAD2 exomes
AF:
0.0587
AC:
14408
AN:
245576
AF XY:
0.0578
show subpopulations
Gnomad AFR exome
AF:
0.0147
Gnomad AMR exome
AF:
0.0217
Gnomad ASJ exome
AF:
0.0361
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.0783
Gnomad NFE exome
AF:
0.100
Gnomad OTH exome
AF:
0.0596
GnomAD4 exome
AF:
0.101
AC:
147413
AN:
1460818
Hom.:
9485
Cov.:
37
AF XY:
0.0976
AC XY:
70901
AN XY:
726626
show subpopulations
African (AFR)
AF:
0.0143
AC:
478
AN:
33406
American (AMR)
AF:
0.0223
AC:
998
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.0399
AC:
1042
AN:
26110
East Asian (EAS)
AF:
0.000176
AC:
7
AN:
39684
South Asian (SAS)
AF:
0.000220
AC:
19
AN:
86236
European-Finnish (FIN)
AF:
0.0807
AC:
4285
AN:
53080
Middle Eastern (MID)
AF:
0.00573
AC:
33
AN:
5764
European-Non Finnish (NFE)
AF:
0.122
AC:
135335
AN:
1111498
Other (OTH)
AF:
0.0864
AC:
5216
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
8410
16820
25229
33639
42049
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4910
9820
14730
19640
24550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0623
AC:
9461
AN:
151872
Hom.:
479
Cov.:
32
AF XY:
0.0579
AC XY:
4302
AN XY:
74246
show subpopulations
African (AFR)
AF:
0.0155
AC:
637
AN:
41182
American (AMR)
AF:
0.0296
AC:
452
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0386
AC:
134
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.0799
AC:
848
AN:
10612
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.106
AC:
7221
AN:
67994
Other (OTH)
AF:
0.0464
AC:
98
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
428
856
1285
1713
2141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0727
Hom.:
265
Bravo
AF:
0.0570
EpiCase
AF:
0.0947
EpiControl
AF:
0.0863

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Dec 24, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.65
DANN
Benign
0.84
PhyloP100
-2.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1150757; hg19: chr6-32029205; API